Literature DB >> 16410947

Spontaneous neutrophil activation in HTLV-1 infected patients.

Jaqueline B Guerreiro1, Maria Aurélia F Porto, Silvane B Santos, Lino Lacerda, John L Ho, Edgar M Carvalho.   

Abstract

Human T cell lymphotropic Virus type-1 (HTLV-1) induces lymphocyte activation and proliferation, but little is known about the innate immune response due to HTLV-1 infection. We evaluated the percentage of neutrophils that metabolize Nitroblue tetrazolium (NBT) to formazan in HTLV-1 infected subjects and the association between neutrophil activation and IFN-gamma and TNF-alpha levels. Blood was collected from 35 HTLV-1 carriers, from 8 patients with HAM/TSP (HTLV-1- associated myelopathy); 22 healthy individuals were evaluated for spontaneous and lipopolysaccharide (LPS)-stimulated neutrophil activity (reduction of NBT to formazan). The production of IFN-gamma and TNF-alpha by unstimulated mononuclear cells was determined by ELISA. Spontaneous NBT levels, as well as spontaneous IFN-gamma and TNF-alpha production, were significantly higher (p<0.001) in HTLV-1 infected subjects than in healthy individuals. A trend towards a positive correlation was noted, with increasing percentage of NBT positive neutrophils and levels of IFN-gamma. The high IFN-gamma producing HTLV-1 patient group had significantly greater NBT than healthy controls, 43+/-24% and 17+/-4.8% respectively (p< 0.001), while no significant difference was observed between healthy controls and the low IFN-gamma-producing HTLV-1 patient group (30+/-20%). Spontaneous neutrophil activation is another marker of immune perturbation resulting from HTLV-1 infection. In vivo activation of neutrophils observed in HTLV-1 infected subjects is likely to be the same process that causes spontaneous IFN-gamma production, or it may partially result from direct IFN-gamma stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410947     DOI: 10.1590/s1413-86702005000600010

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  7 in total

1.  IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.

Authors:  G E A Brito-Melo; V Peruhype-Magalhães; A Teixeira-Carvalho; E F Barbosa-Stancioli; A B F Carneiro-Proietti; B Catalan-Soares; J G Ribas; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

2.  Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Authors:  Shelene K W Poetker; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Marina F Caskey; Edgar M Carvalho; Marshall J Glesby
Journal:  J Clin Virol       Date:  2011-03-08       Impact factor: 3.168

3.  Evaluation of the microbicidal activity and cytokines/chemokines profile released by neutrophils from HTLV-1-infected individuals.

Authors:  Caroline A Bezerra; Thiago M Cardoso; Angela Giudice; Aurélia F Porto; Silvane B Santos; Edgar M Carvalho; Olívia Bacellar
Journal:  Scand J Immunol       Date:  2011-09       Impact factor: 3.487

4.  S100A8 and S100A9 inhibit neutrophil oxidative metabolism in-vitro: involvement of adenosine metabolites.

Authors:  Herve Y Sroussi; Yu Lu; Qin L Zhang; Dana Villines; Phillip T Marucha
Journal:  Free Radic Res       Date:  2010-04

Review 5.  Human T-lymphotropic virus type 1 and novel coronavirus disease 2019; More complex than just a simple coinfection.

Authors:  Samaneh Sajjadi; Sepideh Hejazi; Sahar Ravanshad; Reza Jafarzadeh Esfehani
Journal:  Gene       Date:  2022-05-13       Impact factor: 3.913

6.  Functional activity of monocytes and macrophages in HTLV-1 infected subjects.

Authors:  Camila F Amorim; Anselmo S Souza; Angela G Diniz; Natália B Carvalho; Silvane B Santos; Edgar M Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

7.  HTLV-1-induced leukotriene B4 secretion by T cells promotes T cell recruitment and virus propagation.

Authors:  Florent Percher; Céline Curis; Eléonore Pérès; Maria Artesi; Nicolas Rosewick; Patricia Jeannin; Antoine Gessain; Olivier Gout; Renaud Mahieux; Pierre-Emmanuel Ceccaldi; Anne Van den Broeke; Madeleine Duc Dodon; Philippe V Afonso
Journal:  Nat Commun       Date:  2017-06-22       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.